Profile data is unavailable for this security.
About the company
Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Company’s subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.
- Revenue in USD (TTM)2.76m
- Net income in USD-7.67m
- Incorporated2008
- Employees40.00
- LocationPanacea Life Sciences Holdings Inc5910 SOUTH UNIVERSITY BLVD, C18-193GREENWOOD VILLAGE 80121United StatesUSA
- Phone+1 (561) 455-4822
- Fax+1 (917) 210-2846
- Websitehttps://panacealife.com/panacea-life-sciences-holdings-inc-enters-into-agreement-to-natural-health-and-wellness-chain-of-retail-locations-in-tampa-florida/
More ▼
Mergers & acquisitions
| Acquired company | PLSH:QBB since announced | Transaction value |
|---|---|---|
| Sierra Sage Herbs LLC | -44.57% | -- |
| Nitro Kava & Kratom-Retail Stores,Tampa,FL(8) | -44.57% | 2.81m |
Data delayed at least 15 minutes, as of May 17 2024 15:13 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc | 0.00 | -25.26m | 2.33m | 7.00 | -- | -- | -- | -- | -184.67 | -184.67 | 0.00 | -9.81 | 0.00 | -- | -- | 0.00 | -301.11 | -215.89 | -- | -476.38 | -- | -- | -- | -- | -- | -132.20 | 10.73 | -- | -- | -- | 27.68 | -- | -- | -- |
| Salarius Pharmaceuticals Inc | 0.00 | -12.54m | 2.34m | 2.00 | -- | 0.3649 | -- | -- | -4.54 | -4.54 | 0.00 | 1.34 | 0.00 | -- | -- | 0.00 | -118.12 | -69.27 | -160.07 | -79.89 | -- | -- | -- | -675.70 | -- | -- | 0.0519 | -- | -- | -- | 60.32 | -- | -- | -- |
| Aclarion Inc | 75.41k | -4.91m | 2.35m | 6.00 | -- | -- | -- | 31.11 | -9.36 | -9.36 | 0.1434 | -0.8819 | 0.0281 | -- | 4.74 | 12,568.33 | -182.77 | -- | -655.74 | -- | -0.4244 | -- | -6,512.90 | -- | -- | -- | 2.83 | -- | 24.75 | -- | 34.38 | -- | -- | -- |
| CanaQuest Medical Corp | 0.00 | -808.55k | 2.36m | -- | -- | -- | -- | -- | -0.0515 | -0.0515 | 0.00 | -0.0371 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
| InMed Pharmaceuticals Inc | 5.63m | -6.08m | 2.38m | 13.00 | -- | 0.1627 | -- | 0.4231 | -1.23 | -1.23 | 0.9284 | 1.75 | 0.4006 | 2.71 | 29.77 | -- | -43.26 | -88.10 | -50.03 | -104.19 | 39.20 | -- | -108.01 | -1,066.11 | 5.80 | -- | 0.00 | -- | 279.60 | -- | 57.27 | -- | 29.56 | -- |
| CNS Pharmaceuticals Inc | 0.00 | -18.85m | 2.39m | 3.00 | -- | -- | -- | -- | -5.76 | -5.76 | 0.00 | -0.7132 | 0.00 | -- | -- | 0.00 | -255.54 | -132.47 | -1,018.78 | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
| Galmed Pharmaceuticals Ltd | 0.00 | -6.91m | 2.40m | 3.00 | -- | 0.1451 | -- | -- | -3.68 | -3.68 | 0.00 | 2.75 | 0.00 | -- | -- | 0.00 | -41.65 | -45.06 | -50.55 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
| Resonate Blends Inc | 16.47k | -1.42m | 2.42m | 6.00 | -- | -- | -- | 147.16 | -0.0178 | -0.0178 | 0.0002 | -0.0247 | 0.0237 | -- | -- | -- | -203.52 | -680.29 | -- | -- | -593.02 | -78.88 | -8,597.33 | -12,895.26 | -- | -0.4691 | 7.89 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.44m | 40.00 | -- | -- | -- | 0.8836 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Aoxing Pharmaceutical Company Inc | 30.11m | -1.46m | 2.46m | 339.00 | -- | 0.0287 | -- | 0.0816 | -0.0192 | -0.0192 | 0.3951 | 0.2507 | 0.496 | 2.32 | 2.56 | -- | -2.41 | -14.54 | -7.06 | -35.45 | 76.19 | 68.51 | -4.85 | -37.69 | 0.7368 | 0.3387 | 0.6052 | -- | 26.88 | 37.20 | -62.49 | -- | -38.80 | -- |
| Qrons Inc | 0.00 | -789.36k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0581 | -0.0581 | 0.00 | -0.109 | 0.00 | -- | -- | 0.00 | -45,235.53 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -5.76 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
| American Green Inc | -100.00bn | -100.00bn | 2.57m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 60 Degrees Pharmaceuticals Inc | 253.57k | -3.99m | 2.58m | 3.00 | -- | -- | -- | 10.18 | -0.6657 | -0.6657 | 0.0456 | 0.8382 | 0.0559 | 0.9638 | 1.83 | 84,523.34 | -84.00 | -- | -- | -- | -87.15 | -- | -1,504.04 | -- | 2.39 | -1.89 | 0.0321 | -- | -50.40 | -- | 35.51 | -- | -- | -- |
| DSwiss Inc | 1.47m | -49.54k | 2.59m | 11.00 | -- | 45.84 | 157.51 | 1.76 | -0.0002 | -0.0002 | 0.0071 | 0.0003 | 3.92 | 154.82 | 54.81 | 133,643.60 | -13.22 | -8.69 | -50.26 | -45.47 | 24.44 | 25.55 | -3.37 | -2.47 | 1.05 | -15.74 | 0.3961 | -- | -20.50 | 46.20 | -688.36 | -- | -66.17 | -- |
| AgriFORCE Growing Systems Ltd | 16.28k | -11.73m | 2.60m | 7.00 | -- | 0.0784 | -- | 159.46 | -14.14 | -14.14 | 0.014 | 1.47 | 0.0008 | -- | 0.408 | 2,325.71 | -59.84 | -78.95 | -84.37 | -109.86 | 16.58 | -- | -72,071.25 | -243,182.50 | 0.6922 | -1.39 | 0.3253 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
Data as of May 17 2024. Currency figures normalised to Panacea Life Sciences Holdings Inc's reporting currency: US Dollar USD
